G01N 2333/212
Moraxellaceae
Official title: Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella or Psychrobacter
G01N2333/212 (Moraxellaceae) appears on 12 US grants and 20 published applications in this corpus.
Search patents in G01N- Granted patents
- 12
- Published applications
- 20
- Assignees
- 15
- Inventors
- 49
- Latest grant
- 6 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 1 | 2 |
| 2015 | 0 | 0 |
| 2016 | 1 | 2 |
| 2017 | 2 | 2 |
| 2018 | 0 | 4 |
| 2019 | 0 | 1 |
| 2020 | 2 | 1 |
| 2021 | 4 | 2 |
| 2022 | 0 | 0 |
| 2023 | 1 | 2 |
| 2024 | 0 | 2 |
| 2025 | 1 | 1 |
By publication year.
Recent patents
- Recombinant Acinetobacter baumannii strain AB50756 May 2025US 12,292,441 B2The Government of the United States, as represented by the Secretary of the Army
- Devices and assays for diagnosis of viral and bacterial infections16 May 2023US 11,650,213 B2Entvantage Diagnostics, Inc.
- Immunogenic compositions containing bacterial outer membrane vesicles and therapeutic uses thereof20 Jul 2021US 11,066,453 B2Biomvis Srl
- Monoclonal antibodies for treatment of microbial infections30 Mar 2021US 10,961,298 B2The Government of the United States, as represented by the Secretary of the Army
- Devices and methods for diagnosis of sinusitis16 Feb 2021US 10,921,320 B2Entvantage Diagnostics, Inc.
- Composition from aronia melanocarpa7 Aug 2025US 2025/0249064 A1Givaudan SA
- Method for diagnosis of lung disease based on antibodies for microbial-derived vesicles24 Oct 2024US 2024/0353425 A1Md Healthcare Inc.
- Method for diagnosing chronic urticaria12 Sep 2024US 2024/0302365 A1Ajou University Industry-Academic Cooperation Foundation
- Antigen binding protein and assays24 Aug 2023US 2023/0266317 A1Glaxosmithkline Biologicals SA
- Fusion protein and method of detecting bacteria having pseudaminic acid4 May 2023US 2023/0140486 A1Academia Sinica
Most cited
By later US patents
- Methods and systems for identification of bacteria in biological fluid using raman spectroscopy and applications of same3US 10,914,683 B2Vanderbilt University · 2021
- Devices and assays for diagnosis of sinusitis3US 9,606,118 B2Entvantage Diagnostics, Inc. · 2017
- Real-time analysis for cross-linked peptides3US 9,612,246 B2University of Washington Though Its Center For Commercialization · 2017
- Devices and assays for diagnosis of sinusitis2US 10,620,221 B2Entvantage Diagnostics, Inc. · 2020
- Immunogenic compositions containing bacterial outer membrane vesicles and therapeutic uses thereof2US 11,066,453 B2Biomvis Srl · 2021